SKU: OPC-MAHACEF-SB-1500
Mahacef SB 1.5 Injection contains Ceftriaxone 1000 mg and Sulbactam 500 mg. It is a prescription antibiotic used under medical supervision for susceptible bacterial infections.
Mahacef SB 1.5 Injection contains Ceftriaxone 1000 mg and Sulbactam 500 mg. It is a prescription antibiotic used under the supervision of a qualified healthcare professional for certain bacterial infections caused by susceptible organisms. Ceftriaxone is a third-generation cephalosporin antibiotic, while Sulbactam is a beta-lactamase inhibitor that may help protect the activity of Ceftriaxone against certain susceptible bacteria.
Mahacef SB 1.5 Injection is intended for administration by a qualified healthcare professional. The appropriate dose, route and duration of treatment depend on the type and severity of infection, the patient's age, body weight, medical history and other clinical factors.
For more pharmaceutical and healthcare products, explore our healthcare product collection.
Mahacef SB 1.5 Injection is a combination antibiotic containing Ceftriaxone 1000 mg and Sulbactam 500 mg. It may be prescribed for selected bacterial infections when the treating healthcare professional considers this combination appropriate.
Ceftriaxone works by interfering with bacterial cell-wall synthesis. Sulbactam inhibits certain beta-lactamase enzymes that can reduce the activity of some beta-lactam antibiotics. The combination may therefore provide complementary antibacterial activity against appropriate susceptible organisms.
Mahacef SB should not be self-administered. It should be prepared and given by an appropriately trained healthcare professional according to the prescribed treatment plan.
Mahacef SB 1.5 Injection may be used for certain bacterial infections when the causative organisms are susceptible to Ceftriaxone and Sulbactam. The exact use is determined by the treating healthcare professional based on the infection site, clinical findings and other relevant factors.
Ceftriaxone-containing antibiotic treatment may be prescribed for selected bacterial respiratory infections when injectable treatment is clinically appropriate.
Mahacef SB may be considered for certain susceptible bacterial urinary tract infections when the healthcare professional determines that this treatment is appropriate.
Some bacterial infections involving the skin and soft tissues may require injectable antibiotic treatment. Mahacef SB may be considered when the suspected or confirmed bacteria are susceptible to the medicine.
Ceftriaxone-containing treatment may be used for selected bacterial infections involving the abdomen when appropriate antibiotic treatment is required.
Depending on the diagnosis and bacterial susceptibility, Ceftriaxone-based treatment may be used for other bacterial infections. The treating healthcare professional should determine whether Mahacef SB is suitable for the individual patient.
Ceftriaxone provides antibacterial activity by interfering with bacterial cell-wall formation. This can help target susceptible bacteria responsible for an infection.
Sulbactam inhibits certain beta-lactamase enzymes produced by bacteria. This may help protect the activity of Ceftriaxone against appropriate susceptible organisms.
Ceftriaxone has activity against a variety of susceptible Gram-positive and Gram-negative bacteria. The actual effectiveness depends on the causative organism and its antibiotic sensitivity.
Mahacef SB is supplied as an injectable antibiotic and may be used in clinical situations where a healthcare professional determines that injectable antibacterial treatment is necessary.
The combined strength is expressed as 1.5 g. Always check the original product packaging for the complete formulation, excipients and preparation instructions.
Ceftriaxone works by interfering with the process bacteria use to form and maintain their cell wall. Disruption of this process can lead to the death of susceptible bacteria.
Sulbactam works mainly by inhibiting certain beta-lactamase enzymes. Some bacteria produce these enzymes to break down beta-lactam antibiotics and reduce their effectiveness.
By inhibiting susceptible beta-lactamases, Sulbactam can help protect the antibacterial activity of Ceftriaxone against appropriate susceptible bacterial organisms.
Mahacef SB 1.5 Injection should be administered by a doctor, nurse or another appropriately trained healthcare professional.
The route of administration should follow the approved product instructions and the prescribing healthcare professional's directions. The injection must be properly prepared and administered using appropriate medical technique.
Patients should not attempt to prepare, reconstitute or inject Mahacef SB themselves unless specifically trained and instructed by a qualified healthcare professional.
The appropriate dose of Mahacef SB is determined by the treating healthcare professional. Dosage can vary according to the type and severity of infection, age, body weight, kidney and liver function and the patient's overall medical condition.
There is no single dose that is suitable for every patient. Do not use a dosage prescribed for another person and do not change the frequency or duration of treatment without medical advice.
Use Mahacef SB for the duration prescribed by your healthcare professional. Do not stop or change treatment without discussing it with your doctor.
Some patients may experience side effects during treatment with Ceftriaxone and Sulbactam. Possible effects can include pain, redness or discomfort at the injection site, diarrhoea, nausea, headache, dizziness, rash and changes in certain laboratory test results.
Temporary pain, tenderness, redness or discomfort may occur at the injection site. Inform your healthcare professional if the reaction becomes severe or does not improve.
Seek immediate medical attention if severe rash, swelling of the face or throat, breathing difficulty, severe dizziness or other signs of a serious allergic reaction occur.
Antibiotic treatment can occasionally be associated with significant diarrhoea. Contact your healthcare professional if diarrhoea is severe, persistent or contains blood.
Tell your doctor about all medicines, supplements and herbal products you are currently taking before receiving Mahacef SB.
Your healthcare professional should review your current medicines and relevant compatibility considerations before preparing and administering the injection.
Do not start, stop or change another medicine during treatment without consulting your doctor or pharmacist.
Tell your doctor if you have kidney disease or reduced kidney function. Your healthcare professional may consider kidney function and other clinical factors when selecting the appropriate treatment and monitoring plan.
Inform your doctor if you have liver disease or abnormal liver function. Your healthcare professional may consider liver function and your overall medical condition while planning and monitoring antibiotic treatment.
If you are pregnant, planning pregnancy or think you may be pregnant, inform your doctor before receiving Mahacef SB. Your healthcare professional will determine whether the medicine is appropriate for your infection and individual circumstances.
If you are breastfeeding, inform your doctor before treatment. Your healthcare professional can assess the need for treatment and advise you about any precautions that may be appropriate.
Mahacef SB is generally administered by a healthcare professional according to a planned treatment schedule. If you miss a scheduled injection or appointment, contact your doctor or healthcare facility as soon as possible.
Do not arrange an extra injection yourself to compensate for a missed dose.
Antibiotics are intended to treat bacterial infections and do not work against viral infections such as most common colds and flu. Unnecessary or inappropriate antibiotic use can contribute to antimicrobial resistance.
Use Mahacef SB only when prescribed and follow the treatment instructions provided by your healthcare professional.
For reliable information about antimicrobial resistance, visit the World Health Organization information on antimicrobial resistance.
You can also explore Mahazone SB 1500mg Injection, another Ceftriaxone and Sulbactam-containing injectable antibiotic product.
Mahacef SB 1.5 Injection is a prescription antibiotic containing Ceftriaxone 1000 mg and Sulbactam 500 mg. It is used for certain susceptible bacterial infections under medical supervision.
It is used for certain bacterial infections when the causative bacteria are susceptible to Ceftriaxone and Sulbactam. The exact use is decided by the treating healthcare professional.
Mahacef SB contains Ceftriaxone 1000 mg + Sulbactam 500 mg, with a combined strength of 1.5 g.
Ceftriaxone interferes with bacterial cell-wall formation, while Sulbactam inhibits certain beta-lactamase enzymes that can reduce the effectiveness of beta-lactam antibiotics.
No. Mahacef SB should be prepared and administered by an appropriately trained healthcare professional.
Tell your doctor about any previous antibiotic allergies, kidney or liver problems, pregnancy or breastfeeding, and all medicines and supplements you currently use.
For more pharmaceutical and healthcare products, visit our healthcare product collection.
This product description is provided for general informational purposes only and does not replace professional medical advice, diagnosis or treatment. Mahacef SB 1.5 Injection is a prescription antibiotic and should be used only under the supervision of a qualified healthcare professional.
Dosage, route, treatment duration and suitability vary according to the patient's infection and medical condition. Always follow your doctor's prescription and check the original product packaging for the latest product information.
| Brand | Mahacef SB |
| Manufacturer | Mankind Pharma Ltd |
| Composition | Ceftriaxone 1000 mg |
| Package | 1 × Vial |
| Ship time | 5-10 Business Days |
Free Shipping
For all oders over $99
Secure Payment
100% secure payment
24/7 Support
Online top support